» Articles » PMID: 33082561

Cross-sectional Quantitative Analysis of the Natural History of TUBA1A and TUBB2B Tubulinopathies

Overview
Journal Genet Med
Publisher Elsevier
Specialty Genetics
Date 2020 Oct 21
PMID 33082561
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: TUBA1A and TUBB2B tubulinopathies are rare neurodevelopmental disorders characterized by cortical and extracortical malformations and heterogenic phenotypes. There is a need for quantitative clinical endpoints that will be beneficial for future diagnostic and therapeutic trials.

Methods: Quantitative natural history modeling of individuals with TUBA1A and TUBB2B tubulinopathies from clinical reports and database entries of DECIPHER and ClinVar. Main outcome measures were age at disease onset, survival, and diagnostic delay. Phenotypical, neuroradiological, and histopathological features were descriptively illustrated.

Results: Mean age at disease onset was 4 (TUBA1A) and 6 months (TUBB2B), respectively. Mortality was equally estimated with 7% at 3.2 (TUBA1A) and 8.0 years (TUBB2B). Diagnostic delay was significantly higher in TUBB2B (12.3 years) compared with TUBA1A tubulinopathy (4.2 years). We delineated the isotype-dependent clinical, neuroradiological, and histopathological phenotype of affected individuals and present brain malformations associated with epilepsy and an unfavorable course of disease.

Conclusion: The natural history of tubulinopathies is defined by the genotype and associated brain malformations. Defined data on estimated survival, diagnostic delay, and disease characteristics of TUBA1A and TUBB2B tubulinopathy will help to raise disease awareness and encourage future clinical trials to optimize genetic testing, family counseling, and supportive care.

Citing Articles

Developmental and Epileptic Encephalopathy: Pathogenesis of Intellectual Disability Beyond Channelopathies.

Medyanik A, Anisimova P, Kustova A, Tarabykin V, Kondakova E Biomolecules. 2025; 15(1).

PMID: 39858526 PMC: 11763800. DOI: 10.3390/biom15010133.


Quantitative natural history modeling of HPDL-related disease based on cross-sectional data reveals genotype-phenotype correlations.

Alecu J, Tam A, Richter S, Quiroz V, Schierbaum L, Saffari A Genet Med. 2024; 27(3):101349.

PMID: 39731469 PMC: 11890929. DOI: 10.1016/j.gim.2024.101349.


Systematic quantitative modeling of the natural history of Aicardi syndrome: A cross sectional study of 245 published cases.

Urban O, Driedger J, Garbade S, Hoffmann G, Kolker S, Ries M Orphanet J Rare Dis. 2024; 19(1):457.

PMID: 39633384 PMC: 11616230. DOI: 10.1186/s13023-024-03375-8.


Primary cilia in Parkinson's disease: summative roles in signaling pathways, genes, defective mitochondrial function, and substantia nigra dopaminergic neurons.

Tian Z, Zhang Y, Xu J, Yang Q, Hu D, Feng J Front Aging Neurosci. 2024; 16:1451655.

PMID: 39364348 PMC: 11447156. DOI: 10.3389/fnagi.2024.1451655.


Developmental and epileptic encephalopathies - therapeutic consequences of genetic testing.

Syrbe S Med Genet. 2024; 34(3):215-224.

PMID: 38835873 PMC: 11006352. DOI: 10.1515/medgen-2022-2145.